Mark James Litton Insider Trading $ALPN ALPINE IMMUNE SCIENCES, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mark James Litton.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mark James Litton. Mark James Litton is Chief Business Officer in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Chief Operating Officer in Athira Pharma, Inc. ($ATHA) and See Remarks in ALPINE IMMUNE SCIENCES, INC. ($ALPN).

Mark James Litton in ALPINE IMMUNE SCIENCES, INC.

Trading Symbol: ALPN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark James Litton: See Remarks
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 08 2019
$ALPN Market Capitalization: $36.22M
$ALPN Previous Close: $2.34

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Mark James Litton in ALPINE IMMUNE SCIENCES, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALDR, ALPN, ATHA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 08 2019ALPNALPINE IMMUNE SCIE ...Litton Mark JamesSee RemarksOption ExerciseA6.5175,000488,25075,000
Feb 08 2019ALPNALPINE IMMUNE SCIE ...Litton Mark JamesSee RemarksOption ExerciseA6.8125,000170,25025,000
Aug 08 2018ALPNALPINE IMMUNE SCIE ...Litton Mark JamesSee RemarksOption ExerciseA6.81150,0001,021,500150,000

Page:   1